These Stocks Have Declined More Than 20%: Should You Buy or Sell? [Podcast]

Silviu
These Stocks Have Declined More Than 20%: Should You Buy or Sell? [Podcast]

Subscribe

What should you do if a stock you own has dropped by 20%, 30%, or even 40%?

We examine prominent companies such as UnitedHealth and six others that are currently facing losses. Instead of buying into emotional reactions, Mike provides a straightforward, practical decision-making framework.

Whether you’re holding onto long-standing favorites or recent letdowns, determine whether it’s time to sell, hold, or purchase more.

Unsure What to Invest In—or When?

Whether you have cash on hand or looking at a portfolio in need of an overhaul, the DSR Investment Roadmap guides you through the chaos and helps you proceed with intent.

Cover of the Investment Roadmap.

This complimentary step-by-step guide addresses the questions that often leave DIY investors stuck:

  • How many stocks should I maintain?
  • When is the appropriate moment to buy?
  • Should I cover every sector?
  • What principles should steer my decisions?
  • Which indicators are truly significant?

Instead of making assumptions, adhere to a tested strategy that enables you to establish (or re-establish) a dividend growth portfolio you can rely on—one step at a time.

—> thedividendguyblog.com/roadmap

You’ll Discover

Your Process > Short-Term Results
Before succumbing to panic over underperforming stocks, assess your overall investment process. Concentrate on what you can control, not the market’s fluctuations.

Real-World Case Studies of Underperformers

  • Apple (AAPL) – Down approximately 20% due to worries about AI advancements and sluggish revenue growth.
  • Target (TGT) – Experiencing a ~25% decrease, influenced by disappointing earnings and faltering sales. Mike remains skeptical about its prospects.
  • UnitedHealth (UNH) – Declined ~40% after being hit by a perfect storm: cyberattacks, legal challenges, and weak forecasts. Mike sees potential for recovery but acknowledges the risks involved.
  • TFI International (TFII) – Struggling with revenue declines in a cyclical trucking sector. Nonetheless, Mike identifies long-term possibilities as they implement their classic acquisition strategies.
  • Apogee (APOG) – Down ~45%, impacted by decreased demand and lackluster guidance. Small cap + cyclicality = significant volatility.
  • Robert Half (RHI) – Talent services company down over 40% as EPS and revenue drop. Solid balance sheet, but doesn’t align with Mike’s investment style.
  • Adentra (ADEN.TO) – Construction materials distributor down 24%. The aftermath of COVID lingers. Could be a speculative hold—or time to part ways.

Understanding Why Stocks Decline—and How to Respond

Representation of the dividend triangle.
  • Examine three layers of decline: overall market, sector-specific